FDA Inspection
Mid-America Transplant Services (dba Mid-America Transplant)Mid-America Transplant Services (dba Mid-America Transplant) – FDA Inspection, Jan 4, 2017
Record Details
This FDA Inspection record concerns Mid-America Transplant Services (dba Mid-America Transplant), with an inspection on January 4, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 4, 2017
- Product Type
- Biologics
View Company Profile
ID · 73a09d26-3e02-4fe8-a0bd-7dc04f8e9e53
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 997610
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Mid-America Transplant Services (dba Mid-America Transplant)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 19, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 30, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 25, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 23, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mid-America Transplant Services (dba Mid-America Transplant)
- FDA Inspection 1247285 - 2024-08-23
- FDA Inspection 1089056 - 2019-04-19
- FDA Inspection 901726 - 2014-10-30
- FDA Inspection 841595 - 2013-07-25
- FDA Inspection 633300 - 2009-11-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.